Both in null
XTL Biopharmaceuticals vs State Street SPDR S&P 500 ETF Trust
Over the past year XTLB returned −54.3% and SPY returned +15.1%; their daily moves had a correlation of 0.02.
XTLB −54.3% SPY +15.1%Growth of $1, one year, split-adjusted
| Metric | XTLB | SPY |
|---|---|---|
| Price | $2.21 | $764.20 |
| Market cap | $5.4M | $815.23B |
| Today | −0.90% | −0.18% |
| 1 month | −10.5% | −0.7% |
| 6 months | −15.3% | +20.9% |
| Year to date | −4.7% | +12.1% |
| 1 year | — | +15.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | — |
| Dividend yield | — | 0.99% |
| Volatility (60d) | 87.4% | 11.1% |
| Short % of float | — | — |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).